Dental markets have reopened following the pandemic peak but the impact may be felt for many months to come, not least because of a second wave winter. HBI has added new post-COVID market size data on the Intelligence platform based on conversations with operators. Most think new national lockdowns are unlikely but regional lockdowns, prolonged economic uncertainty for patients, and scared patients are all causing concern.
Switzerland's largest private hospital group Hirslanden's investment in a self-proclaimed 'disruptive' procurement outfit does not affect its cooperation with the procurement hub of German hospital Sana, parent company Mediclinic tells HBI. But the group has yet to reveal what it has gotten out of the cooperation with Sana.
Switzerland's second-largest for-profit hospital group Swiss Medical Network (SMN) has acquired a primary and outpatient care centre in Bern, but the deal was "not done to steer more patients to the group’s hospitals," a spokesperson tells us. We look at the primary care market in Switzerland and how SMN's approach to it differs from competitors.
HBI talks to Stefan Nilsson, CEO of Colosseum Dental Group, the Swiss-based pan-European chain with a presence in Finland, Norway, Sweden, Switzerland, Italy, Denmark, Germany and the UK, about how it has weathered COVID, and its plans going forward as we all adapt to the new normal.
Conglomerate Aevis Victoria is open to selling a stake in its hospital chain Swiss Medical Network to an insurer to help it move towards an integrated payor-provider model, co-founder and delegate of the board Antoine Hubert tells HBI. We catch up on pre- and post-COVID developments in the Swiss hospital sector.
Investment bank Jefferies has cut its price target for three major EMEA acute healthcare stocks by 33-50%. One of them, Mediclinic International, has confirmed HBI's recent reports of a quick rebound in the Swiss and UAE markets in June.
Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.
For-profit hospitals across West Europe are ramping up activity as governmental financial protections are slowly phased out, but it's taking much longer than in outpatient facilities and varies wildly from country to country. Why? HBI looks at the situation in Germany, France, Switzerland, the UK and Ireland.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
